Table 1

Characteristics of the cohort at baseline, according to marital status and immigrant status

Marital statusImmigrant status
SingleDivorcedMarried/cohabitingWidowedSwedish nativeImmigrant
Individuals, n13,5602,2668,80029423,3821,565
Males7,863 (58.0)1,058 (46.7)4,411 (50.1)71 (24.1)12,659 (54.1)756 (48.3)
Age (years)32.07 (10.87)49.00 (10.58)46.81 (12.11)64.05 (11.22)39.22 (13.93)38.81 (12.74)
Onset age (years)14.36 (7.41)16.82 (7.93)16.98 (7.82)17.17 (7.58)15.29 (7.67)19.30 (7.42)
Income, n (%)
 Q14,036 (29.8)265 (11.7)1,430 (16.2)64 (21.8)5,242 (22.4)553 (35.6)
 Q22,759 (20.3)545 (24.1)1,417 (16.1)84 (28.6)4,491 (19.2)314 (20.2)
 Q32,604 (19.2)487 (21.5)1,669 (19.0)39 (13.3)4,505 (19.3)294 (18.9)
 Q42,350 (17.3)471 (20.8)1,844 (21.0)42 (14.3)4,490 (19.2)217 (14.0)
 Q51,811 (13.4)498 (22.0)2,440 (27.7)65 (22.1)4,637 (19.8)177 (11.4)
Education, n (%)
 ≤9 years2,037 (15.2)483 (21.4)1,415 (16.1)117 (40.2)3,707 (15.9)345 (23.3)
 10–12 years7,507 (55.9)1,210 (53.5)4,292 (49.0)124 (42.6)12,466 (53.6)667 (45.0)
 College/university3,877 (28.9)567 (25.1)3,055 (34.9)50 (17.2)7,080 (30.4)469 (31.7)
Marital status, n (%)
 SingleN/AN/AN/AN/A12,967 (55.5)593 (38.1)
 DivorcedN/AN/AN/AN/A2,047 (8.8)219 (14.1)
 Married/cohabitingaN/AN/AN/AN/A8,078 (34.6)722 (46.4)
 WidowedN/AN/AN/AN/A273 (1.2)21 (1.4)
Immigrant, n (%)593 (4.4)219 (9.7)722 (8.2)21 (7.1)N/AN/A
CSII, n (%)1,750 (14.7)221 (11.3)1,210 (15.5)17 (6.5)3,093 (14.9)110 (9.1)
HbA1c (mmol/mol)64.89 (15.74)65.65 (14.39)62.67 (13.04)62.30 (11.68)64.06 (14.59)65.31 (16.54)
eGFR (mL/min)98.25 (27.69)84.61 (28.15)86.03 (24.87)69.91 (22.31)91.65 (26.95)100.07 (34.0)
Systolic BP (mmHg)123.70 (14.53)131.69 (16.83)129.87 (16.26)138.31 (18.01)126.88 (15.77)125.89 (16.6)
Chol-to-HDL ratio3.18 (1.05)3.10 (1.03)3.04 (1.00)2.89 (0.84)3.11 (1.02)3.30 (1.13)
BMI (kg/m2)25.32 (4.35)25.76 (4.38)26.00 (4.19)25.33 (4.87)25.55 (4.26)26.50 (4.98)
Smoker, n (%)1,670 (12.9)429 (19.4)801 (9.3)43 (14.9)2,657 (11.7)288 (19.7)
Exercise, n (%)
 Never866 (9.1)211 (13.5)526 (8.5)28 (14.6)1,486 (9.0)148 (14.0)
 <1 time/week1,248 (13.1)233 (14.9)789 (12.7)24 (12.5)2,127 (12.9)170 (16.0)
 1–2 times/week2,663 (27.9)377 (24.2)1,810 (29.2)41 (21.4)4,645 (28.2)248 (23.4)
 3–5 times/week2,708 (28.4)334 (21.4)1,529 (24.6)40 (20.8)4,379 (26.6)238 (22.5)
 Daily2,064 (21.6)406 (26.0)1,552 (25.0)59 (30.7)3,830 (23.3)256 (24.2)
Albuminuria, n (%)
 Microalbuminuria1,473 (11.8)389 (17.9)1,318 (15.4)55 (19.2)3,036 (13.7)202 (14.5)
 Macroalbuminuria688 (5.5)223 (10.3)640 (7.5)26 (9.1)1,462 (6.6)119 (8.6)
Antihypertensives, n (%)2,688 (20.5)1,016 (45.6)3,520 (40.5)184 (63.4)6,967 (30.5)450 (29.9)
Statins, n (%)1,766 (13.5)743 (33.5)2,747 (31.8)124 (43.1)5,055 (22.2)332 (22.2)
Aspirin889 (6.9)525 (24.0)1,706 (20.0)108 (37.9)3,031 (13.5)201 (13.5)
HF, n (%)52 (0.4)25 (1.1)70 (0.8)8 (2.7)144 (0.6)12 (0.8)
AF, n (%)29 (0.2)14 (0.6)75 (0.9)10 (3.4)114 (0.5)14 (0.9)
IHD, n (%)30 (0.2)32 (1.4)91 (1.0)9 (3.1)148 (0.6)14 (0.9)
  • Data are crude baseline values as means ± 1 SD unless otherwise indicated. BP, blood pressure; Chol-to-HDL ratio, total cholesterol–to–HDL ratio; IHD, ischemic heart disease. aCohabiting as registered partners.